What is Healthcare Tr Amer Inc's earnings per share (EPS)?

Healthcare Tr Amer Inc (HR) reported diluted earnings per share of $-0.71 for fiscal year 2025. This represents a 60.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthcare Tr Amer Inc Financials

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Healthcare Tr Amer Inc (HR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

6/9

Healthcare Tr Amer Inc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-1.86x

For every $1 of reported earnings, Healthcare Tr Amer Inc generates $-1.86 in operating cash flow ($457.1M OCF vs -$246.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY-6.9%

5Y CAGR+18.8%

10Y CAGR+11.3%

Healthcare Tr Amer Inc generated $1.2B in revenue in fiscal year 2025. This represents a decrease of 6.9% from the prior year.

EBITDA

N/A

Net Income

-$246.1M

YoY+62.4%

Healthcare Tr Amer Inc reported -$246.1M in net income in fiscal year 2025. This represents an increase of 62.4% from the prior year.

EPS (Diluted)

$-0.71

YoY+60.8%

Healthcare Tr Amer Inc earned $-0.71 per diluted share (EPS) in fiscal year 2025. This represents an increase of 60.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$26.2M

YoY-62.0%

5Y CAGR-25.7%

10Y CAGR+7.2%

Healthcare Tr Amer Inc held $26.2M in cash against $3.9B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.10

YoY-11.3%

5Y CAGR-1.7%

10Y CAGR-0.6%

Healthcare Tr Amer Inc paid $1.10 per share in dividends in fiscal year 2025. This represents a decrease of 11.3% from the prior year.

Shares Outstanding

349M

YoY-0.6%

5Y CAGR+9.8%

Healthcare Tr Amer Inc had 349M shares outstanding in fiscal year 2025. This represents a decrease of 0.6% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

-20.8%

YoY+30.8pp

5Y CAGR-35.3pp

10Y CAGR-29.0pp

Healthcare Tr Amer Inc's net profit margin was -20.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 30.8 percentage points from the prior year.

Return on Equity

-5.3%

YoY+7.2pp

5Y CAGR-9.0pp

10Y CAGR-7.7pp

Healthcare Tr Amer Inc's ROE was -5.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 7.2 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$4.0M

YoY-54.9%

5Y CAGR+22.8%

10Y CAGR+9.2%

Healthcare Tr Amer Inc spent $4.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 54.9% from the prior year.

Capital Expenditures

N/A

HR Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.2B-6.9%	$1.3B-5.6%	$1.3B+44.1%	$932.6M+74.4%	$534.8M+7.0%	$499.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$72.6M-12.7%	$83.1M+42.3%	$58.4M+10.8%	$52.7M+54.4%	$34.2M+11.2%	$30.7M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$209.0M-13.8%	$242.4M-6.2%	$258.6M+76.3%	$146.7M+176.1%	$53.1M-5.4%	$56.2M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$246.1M+62.4%	-$654.5M-135.2%	-$278.3M-780.4%	$40.9M-38.6%	$66.7M-7.7%	$72.2M
EPS (Diluted)	$-0.71+60.8%	$-1.81-144.6%	$-0.74-593.3%	$0.15-66.7%	$0.45-13.5%	$0.52

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$286.3M-3.8%	$297.8M+0.1%	$297.5M-0.5%	$299.0M-3.5%	$309.8M-1.8%	$315.4M-0.3%	$316.3M-3.2%	$326.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$13.8M-36.7%	$21.8M-7.3%	$23.5M+73.6%	$13.5M-60.4%	$34.2M+70.0%	$20.1M+43.7%	$14.0M-5.3%	$14.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$48.2M-8.5%	$52.6M-1.3%	$53.3M-2.7%	$54.8M-5.9%	$58.3M-3.9%	$60.6M-2.9%	$62.5M+2.3%	$61.1M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$14.4M+124.9%	-$57.7M+63.4%	-$157.9M-251.8%	-$44.9M+58.0%	-$106.8M-14.9%	-$93.0M+35.3%	-$143.8M+53.7%	-$310.8M
EPS (Diluted)	N/A	$-0.17+62.2%	$-0.45-246.2%	$-0.13	N/A	$-0.26+33.3%	$-0.39+52.4%	$-0.82

HR Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$9.2B-13.5%	$10.7B-15.7%	$12.6B-8.8%	$13.8B+225.2%	$4.3B-37.3%	$6.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$26.2M-62.0%	$68.9M+168.2%	$25.7M-57.8%	$61.0M+362.7%	$13.2M-88.6%	$115.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$32.8M-10.1%	$36.5M-42.3%	$63.2M+15.6%	$54.7M+288.5%	$14.1M-20.6%	$17.7M
Goodwill	N/A	$0-100.0%	$250.5M+12.2%	$223.2M+6301.0%	$3.5M	N/A
Total Liabilities	$4.5B-15.2%	$5.3B-6.5%	$5.7B-7.4%	$6.2B+197.4%	$2.1B-41.7%	$3.6B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$3.9B-16.1%	$4.7B-6.6%	$5.0B-6.7%	$5.4B+197.1%	$1.8B-40.5%	$3.0B
Total Equity	$4.6B-11.8%	$5.2B-23.3%	$6.8B-9.9%	$7.6B+246.5%	$2.2B+12.2%	$1.9B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$9.2B-6.6%	$9.9B-3.7%	$10.2B-2.5%	$10.5B-1.5%	$10.7B-5.3%	$11.2B-4.7%	$11.8B-3.9%	$12.3B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$26.2M-39.6%	$43.3M+69.9%	$25.5M-0.8%	$25.7M-62.7%	$68.9M+202.2%	$22.8M-45.4%	$41.8M+59.6%	$26.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$32.8M	N/A	N/A	N/A	$36.5M	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	$0	$0	$0	$0
Total Liabilities	$4.5B-11.4%	$5.1B-4.5%	$5.4B+0.1%	$5.3B+0.1%	$5.3B-5.3%	$5.6B-3.2%	$5.8B+1.0%	$5.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$3.9B-12.8%	$4.5B-4.4%	$4.7B-0.8%	$4.7B+1.5%	$4.7B-6.0%	$5.0B-3.7%	$5.1B+0.8%	$5.1B
Total Equity	$4.6B-1.4%	$4.7B-2.8%	$4.8B-5.1%	$5.1B-3.0%	$5.2B-5.1%	$5.5B-6.3%	$5.9B-8.2%	$6.4B
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HR Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$457.1M-8.9%	$501.6M+0.4%	$499.8M+83.3%	$272.7M+17.2%	$232.6M-50.5%	$470.1M
Capital Expenditures	N/A	N/A	N/A	N/A	$97.2M+30.0%	$74.7M
Free Cash Flow	N/A	N/A	N/A	N/A	$135.5M-65.7%	$395.3M
Investing Cash Flow	$710.8M-21.1%	$900.9M+158.0%	$349.1M-78.6%	$1.6B+390.6%	-$562.5M-1.3%	-$555.2M
Financing Cash Flow	-$1.2B+10.9%	-$1.4B-53.7%	-$884.2M+52.4%	-$1.9B-667.4%	$327.7M+228.6%	$99.7M
Dividends Paid	$386.9M-15.5%	$457.9M-3.0%	$472.2M+66.5%	$283.7M+61.7%	$175.5M+7.9%	$162.6M
Share Buybacks	$4.0M-54.9%	$8.9M+286.5%	$2.3M-28.0%	$3.2M-16.1%	$3.8M+164.8%	$1.4M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$132.3M+16.3%	$113.8M-30.3%	$163.2M+241.5%	$47.8M-65.4%	$138.0M+15.7%	$119.3M-29.1%	$168.2M+120.8%	$76.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$526.5M+132.7%	$226.3M+7403.9%	-$3.1M+92.0%	-$38.8M-109.3%	$418.8M+26.6%	$330.8M+57.5%	$209.9M+458.5%	-$58.6M
Financing Cash Flow	-$676.1M-109.9%	-$322.2M-101.1%	-$160.2M-207.2%	-$52.1M+89.9%	-$514.0M-10.4%	-$465.7M-28.5%	-$362.5M-2017.7%	-$17.1M
Dividends Paid	$84.4M-0.4%	$84.8M-22.2%	$108.9M+0.1%	$108.8M-0.9%	$109.8M-2.4%	$112.4M-4.2%	$117.3M-0.8%	$118.3M
Share Buybacks	$379K-87.0%	$2.9M+485.3%	$498K+131.6%	$215K-97.5%	$8.6M	$0-100.0%	$3K-99.1%	$318K

HR Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-20.8%+30.8pp	-51.6%-30.9pp	-20.7%-25.1pp	4.4%-8.1pp	12.5%-2.0pp	14.4%
Return on Equity	-5.3%+7.2pp	-12.5%-8.4pp	-4.1%-4.6pp	0.5%-2.5pp	3.0%-0.7pp	3.7%
Return on Assets	-2.7%+3.5pp	-6.1%-3.9pp	-2.2%-2.5pp	0.3%-1.3pp	1.6%+0.5pp	1.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.85-0.0	0.89+0.2	0.73+0.0	0.71-0.1	0.82-0.7	1.55
FCF Margin	N/A	N/A	N/A	N/A	25.3%-53.8pp	79.1%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	5.0%+24.4pp	-19.4%+33.7pp	-53.1%-38.0pp	-15.0%+19.5pp	-34.5%-5.0pp	-29.5%+16.0pp	-45.5%+49.7pp	-95.1%
Return on Equity	0.3%+1.5pp	-1.2%+2.1pp	-3.3%-2.4pp	-0.9%+1.2pp	-2.0%-0.4pp	-1.7%+0.8pp	-2.4%+2.4pp	-4.8%
Return on Assets	0.2%+0.8pp	-0.6%+1.0pp	-1.5%-1.1pp	-0.4%+0.6pp	-1.0%-0.2pp	-0.8%+0.4pp	-1.2%+1.3pp	-2.5%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.85-0.1	0.96-0.0	0.97+0.0	0.93+0.0	0.890.0	0.90+0.0	0.87+0.1	0.80
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

AMERICAN HEALTHCARE REIT INC AHR

$9.0B

Caretrust CTRE

$8.6B

Sabra Health Care Reit Inc SBRA

$5.0B

National Health Investors NHI

$4.0B

Medical Prop MPW

$3.0B

Frequently Asked Questions

What is Healthcare Tr Amer Inc's annual revenue?

Healthcare Tr Amer Inc (HR) reported $1.2B in total revenue for fiscal year 2025. This represents a -6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Tr Amer Inc's revenue growing?

Healthcare Tr Amer Inc (HR) revenue declined by 6.9% year-over-year, from $1.3B to $1.2B in fiscal year 2025.

Is Healthcare Tr Amer Inc profitable?

No, Healthcare Tr Amer Inc (HR) reported a net income of -$246.1M in fiscal year 2025, with a net profit margin of -20.8%.

How much debt does Healthcare Tr Amer Inc have?

As of fiscal year 2025, Healthcare Tr Amer Inc (HR) had $26.2M in cash and equivalents against $3.9B in long-term debt.

What is Healthcare Tr Amer Inc's net profit margin?

Healthcare Tr Amer Inc (HR) had a net profit margin of -20.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Healthcare Tr Amer Inc pay dividends?

Yes, Healthcare Tr Amer Inc (HR) paid $1.10 per share in dividends during fiscal year 2025.

What is Healthcare Tr Amer Inc's return on equity (ROE)?

Healthcare Tr Amer Inc (HR) has a return on equity of -5.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Tr Amer Inc's operating cash flow?

Healthcare Tr Amer Inc (HR) generated $457.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthcare Tr Amer Inc's total assets?

Healthcare Tr Amer Inc (HR) had $9.2B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Healthcare Tr Amer Inc buy back shares?

Yes, Healthcare Tr Amer Inc (HR) spent $4.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthcare Tr Amer Inc have outstanding?

Healthcare Tr Amer Inc (HR) had 349M shares outstanding as of fiscal year 2025.

What is Healthcare Tr Amer Inc's debt-to-equity ratio?

Healthcare Tr Amer Inc (HR) had a debt-to-equity ratio of 0.85 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthcare Tr Amer Inc's return on assets (ROA)?

Healthcare Tr Amer Inc (HR) had a return on assets of -2.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Tr Amer Inc's Piotroski F-Score?

Healthcare Tr Amer Inc (HR) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Tr Amer Inc's earnings high quality?

Healthcare Tr Amer Inc (HR) has an earnings quality ratio of -1.86x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.